Tivlemaq 30 mg filmom obložene tablete
| Name | Tivlemaq 30 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-629196570 |
| Active Substance | apremilast |
| Composition | svaka filmom obložena tableta sadrži 30 mg apremilasta |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 13.05.2024 |
| MA Period of Validity | 13.05.2029 |
| Classification Number | UP/I-530-09/23-01/32 |
| Registration Number | 381-12-01/171-24-07 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L04AA32 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
